ARIC Manuscript Proposal #1377
|
|
- Gwendoline Rose
- 5 years ago
- Views:
Transcription
1 ARIC Manuscript Proposal #1377 PC Reviewed: 06/10/08 Status: A Priority: 2 SC Reviewed: Status: Priority: 1. a. Full Title: Relationship between pulmonary disease, lung function and incident hospitalized heart failure: The Atherosclerosis risk in communities (ARIC) study b. Abbreviated Title (Length 26 characters): Lung function and heart failure 2. Writing Group: Sunil Kumar Agarwal, Dalane W. Kitzman, Laura Loehr, Naresh Punjabi (response awaited) Eyal Shahar I, the first author, confirm that all the coauthors have given their approval for this manuscript proposal. SKA First author: Sunil Kumar Agarwal Address: Department of Epidemiology School of Public Health University of North Carolina at Chapel Hill sunilagarwal@unc.edu Phone: (919) Fax: (919) Corresponding/senior author: Gerardo Heiss gerardo_heiss@unc.edu Phone: (919) Fax: (919) Timeline: Approval of this manuscript by the ARIC Publications Committee will then enable work on this manuscript. Once started, this work will lead to manuscript(s) within 15 months. 4. Rationale: Heart Failure (HF) is a major public health problem in the US [1] while it has a grim prognosis (30% mortality at one year)[2], its cost of treatment exceeds those for both coronary artery disease and cancer combined accounting for about 5.4% of the total US health care cost [3]. HF is a common comorbidity among patients with chronic obstructive airway disease (COAD), and vice versa [4, 5]. Both of the above conditions may present with symptoms of dyspnea and orthopnea. Furthermore, evidence of airway obstruction and bronchodilator response on pulmonary function testing may be evident not only in COAD but also in HF[6]. Thus, COAD complicates both the diagnosis and treatment of heart failure. Recent research has shown that immunization with the influenza (a disease mainly affecting the lungs) vaccine prevents new onset of heart failure [7]. However, little literature is available about the relationship between lung disease (and functional state) with incident heart failure. 1
2 Several studies have reported higher cardiovascular mortality among individuals with lower lung function and COAD. Factors such as chronic muscle wasting, autonomic dysfunction, systemic inflammation[8], or oxidative stress may be responsible for this increased risk. [9] To the best of our knowledge, there is no literature on existing COPD diagnosis and risk of incident hospitalized HF. Lung function is typically assessed using standardized spirometry determined forced vital capacity (FVC), forced expiratory volume during initial 1 second duration (FEV1) and their ratio (FVC/FEV1). Vital capacity (VC) is reduced during decompensated HF and its measurement is recommended to evaluate response to therapy[10]. However, there is no mention of lung disease/assessment for risk stratification or management in the recent ACC/AHA guidelines for HF [11]. Further, little is known about the risk of heart failure in individuals with reduced lung function (vital capacity (height adjusted), FEV1, FEV1/FVC). A study by Kannel et al, found that vital capacity is an indirect marker of left ventricular performance. It is decreased in individuals with left ventricular dysfunction (LVD) possibly due to weakness of respiratory muscles, increase in lung fluid, adverse changes in lung mechanics (decreased compliance or a large closing volume), and increase in myocardial mass without a concomitant rise in central and pulmonary vascular blood volume[12]. In the above study, reduced FVC, but not obstructive lung disease as defined by reduced FEV1/total VC, was found to be associated with incident heart failure[12]. Other studies have shown that reduced FEV1[13], peak expiratory flow rate[14] are associated with incident HF. To some extent, the above associations might reflect misclassification of dyspnea due to lung disease as CHF, as well as the concordance of age-related decrease in pulmonary function with increases in incident CHF. In addition to aging, a few risk factors such as smoking, obesity, anemia and air pollution (high particulate matter concentration), have adverse effect on both lung function and CAD risk. In addition, beta blockers which are used to treat heart failure, may exacerbate symptoms of underlying COPD. The effect of smoking in the causation of CAD and subsequent systolic HF has been documented. Cigarette smoking may act through other pathways leading to damage to the lung parenchyma further leading to pulmonary hypertension, and diastolic heart failure. This is supported by a study showing a greater decline in FEV1 among lifelong smokers as compared to never-smokers [15]. In the study by Kannel et al, association between lung function and incident HF existed even after adjustment for smoking [12]. A recent ARIC study showed greater decline in lung function in diabetics as compared to non-diabetics implicating blood sugar dysregulation in causing lung injury[16]. In addition to increasing the risk of incident CAD and subsequent systolic heart failure; obesity may predispose to diastolic dysfunction[17, 18] and subsequent CAD and heart failure via sleep-disordered breathing (intermittent hypoxemia, hypertension and arrhythmias (atrial fibrillation))[19]. Air pollution (PM) is associated with lower heart rate variability and higher levels inflammatory markers, and increased CVD related mortality in the ARIC cohort. Also, anemia is common in patients with COAD and is associated with increased risk of incident HF. 2
3 Vital capacity shows weak negative correlation with blood sugar, blood pressure, serum cholesterol and heart enlargement especially in the elderly [20]. The strongest correlation was seen with handgrip muscle strength[20]. Also, higher FEV1 has been associated with favorable cardiovascular risk profile (BP, T2DM, cholesterol, fibrinogen, WBC, and BMI)[21, 22]. Low VC is also associated with incident diabetes[22, 23], left ventricular hypertrophy[24], sub-clinical atherosclerosis (measured by ankle-brachial index and intimamedia thickness)[25], and incident ischemic cardiac disease [8, 24, 26-28]. The goals of this proposal are to assess the relationship between chronic lung disease, lung function and incident HF. Since there may be a differential relationship by race, the ARIC cohort provides an opportunity to explore the higher risk of HF seen in African Americans in the framework outlined above. Also, socio-economic status (confounded by race in ARIC), may be an important determinant of lung function and the lung function-heart failure relationship. We expect this relationship to differ by co-morbidities and to be attenuated by adjustment for variables possibly on the causal pathway. This relationship (if present) may help in risk stratification, improve understanding of biologic mechanisms and may provide evidence for research to further understanding of the lung-heart relationship and preventive strategies. We hypothesize that poor lung function at study baseline in individuals without HF is associated with increased risk of subsequent HF; this relationship is stronger in those with CAD, smokers, and those with diabetes ; and will be attenuated after adjustment for inflammatory, pro-coagulability and metabolic derangement markers. 5. Main Hypothesis/Study Questions: The following questions will be addressed with special attention to race and gender. 1. Estimate the proportion of individuals with HF (self reported HF and incident hospitalized HF) who have prevalent COAD in general population. 2. Quantify the association of COAD (self reported and GOLD classification) at study baseline with increased risk of incident hospitalized HF. a. The above relation is modified by smoking, obesity and baseline comorbidity (CAD and Diabetes), individually. 3. Estimate the association of lung function (FVC, FEV1, and FEV1/FVC, after appropriate adjustments for gender and height) with risk of incident hospitalized HF. a. The above relation is modified by smoking, obesity and baseline comorbidity (CAD and Diabetes). b. The above relationship exists in the subset of cohort without CAD prior to incident HF. c. The above relation becomes weaker after adjusting for potential markers of inflammation, hypercoagulability, SES, maximal inspiratory pressure (MIP) available in ARIC cohort, as these may be intermediary in the observed association. 4. Individuals with greater decline in lung function (between visit 1 and visit 2) are at higher risk of incident hospitalized HF after adjusting for baseline function (visit 1). 3
4 Analytical methods: Proportions of individuals with heart failure and respiratory comorbidity will be reported both at ARIC cohort baseline visit (self reported) and at first hospitalization with heart failure (ICD codes). Prevalent HF will be defined as the reported current intake of HF medication at the baseline examination (n = 83) or evidence of manifest HF as defined by the Gothenburg criteria stage 3 (n = 669), which require the presence of specific cardiac and pulmonary symptoms as well as medical treatment of HF[14]. By January 1 st, 2003, 1193 study participants met these incident HF criteria. Analyses for this study will include additional incident HF events i.e., through Those who had incident HF mentioned in the death certificate (n= 78) will be included in a sub-analysis (as their characteristics may be different, HF due to circulatory collapse, sepsis etc.) Cox proportional hazards regression models will be used to assess the relationship between lung disease (self reported and modified GOLD classification) and incident HF. Racial and gender differences will be explored in subgroup analysis. Also, effect modification will be examined for smoking and other comorbidity. At study baseline there were 54% neversmoker women and 30% never smoker men. Similarly, Cox regression models will be used to examine the relationship between functional measures FVC, FEV1 (divided by quartiles) and incident heart failure. Effect modification will be examined by smoking, obesity and comorbidities. A subgroup analysis will be done restricting sample to individuals who didn t report or were not diagnosed with AMI prior to HF hospitalization. The reduction in hazard ratio will be evaluated after adjustment for proinflamatory and pro-coagulability markers (intermediaries) in a model adjusted for potential confounders (age, gender, height etc.) PHA will be examined for the main exposure and all covariates with log log curves and time interaction terms (Cox test). Linearity of log (HR) will be examined. Variables requested: Visit 1: Lung function test (FVC, FEV1), demographics (age, gender, race, center), Socio economic indicators (education and income), anthropometric measures (height, BMI, waist circumference, waist-hip ratio), comorbidites and CVD risk factors (CAD, COAD, CHF, T2DM, hypertension, LDL-cholesterol, HDL cholesterol), inflammatory and hemostatic markers (albumin, fibrinogen), von Willebrand factor (vwf), fibrinogen, D-dimer, factor VII, factor VIII, PAI-1, tpa, beta-thromboglobulin (beta-tg), CRP, and WBC count). Smoking? Visit 2: Lung function test (FVC, FEV1), MIP Follow up through 2004: incident CAD, incident hospitalized HF. 7.a. Will the data be used for non-cvd analysis in this manuscript? No 7.b. NA 8.a. Will the DNA data be used in this manuscript? No 8.b. NA 4
5 9. The lead author of this manuscript proposal has reviewed the list of existing ARIC Study manuscript proposals and has found no overlap between this proposal and previously approved manuscript proposals either published or still in active status. No overlaps 10. What are the most related manuscript proposals in ARIC (authors are encouraged to contact lead authors of these proposals for comments on the new proposal or collaboration)? Proposals looking at risk factors of HF: MP#922 Alcohol consumption and risk of congestive heart failure MP#927 Heart Failure Incidence and Survival: 13 Year Follow up of the ARIC Cohort MP#1118 Kidney Function as a Risk Factor for Incident Heart Failure MP#1125 Diabetes, obesity and insulin resistance as risk factors for incident hospitalized HF MP#1144 The Obesity Paradox in Heart Failure. MP#1160 Life Course Socioeconomic Exposures and Heart Failure. MP# 1164 Hemoglobin A1c as a Risk Factor for HF Hospitalization among Persons with Diabetes. MP#1197 Albuminuria as a Predictor of Incident Heart Failure Hospitalization and Mortality. MP#1232 ECG Abnormalities Preceding Heart Failure: Estimation and Prediction MP#1276 Exhaustion and risk for congestive heart failure. Other Proposals with HF as focus: MP#855 - Retinal Microvascular Abnormalities and Congestive Heart Failure MP#617 - Evaluation of ICD Codes to Identify Hospitalized MI Patients with Acute Congestive HF. MP#890B -Plasma Fatty Acid Composition and Incidence of Heart Failure in Middle Aged Adults MP# Prevalence and Prognosis of ALVSD in African Americans MP# Outpatient Surveillance of Heart Failure. MP# Neighborhood and Individual Socioeconomic Status and Heart Failure Rehospitalization MP# Socioeconomic, demographic and clinical predictors of heart failure care. Other proposals with lung function as focus: MP#56 Lung function and ultrasound (M) MP#1356 Dietary Dairy Intake, Lung Function, and Chronic Obstructive Pulmonary Disease (COPD) MP#551 Race and gender differences in the effects of smoking on lung function: a meta-analysis MP#849 Low lung infraction and incident lung career MP#850 Low lung function, lung function decline, and outcomes MP#851 The metabolic syndrome and low lung function MP#1080 Lung function, asthma, and coronary heart disease (CHD) severity MP#1091 Impaired Lung Function Associated with Polymorphisms in Beta-Adrenergic Receptors (ADRB) and Endothelin Receptors (EDNR) MP#1220 Relationship of Lung Function with ARMD and Retinal Vascular Disease MP#1239 Matrix Metalloproteinase Polymorphisms Associated with Impaired LF and COPD MP#1311 Serum uric acid, lung function and chronic obstructive pulmonary disease in adults MP#1356 Dietary Dairy Intake, Lung Function, and Chronic Obstructive Pulmonary Disease (COPD) 11. a. Is this manuscript proposal associated with any ARIC ancillary studies or use any ancillary study data? No 11.b. If yes, is the proposal NA 12. Manuscript preparation is expected to be completed in one to three years. The authors are aware of this fact. 5
6 References: 1. Garg, R., et al., Heart failure in the 1990s: evolution of a major public health problem in cardiovascular medicine. J Am Coll Cardiol, (4 Suppl A): p. 3A-5A. 2. Levy, D., et al., Long-term trends in the incidence of and survival with heart failure. N Engl J Med, (18): p O'Connell, J.B. and M.R. Bristow, Economic impact of heart failure in the United States: time for a different approach p. S Rutten, F.H., et al., Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail, (7): p Dahlstrom, U., Frequent non-cardiac comorbidities in patients with chronic heart failure. Eur J Heart Fail, (3): p Cabanes, L.R., et al., Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function. N Engl J Med, (20): p Davis, M.M., et al., Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation, (14): p Schroeder, E.B., et al., Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol, (12): p Mannino, D.M., D.E. Doherty, and A. Sonia Buist, Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med, (1): p Levine, S.A., The value of determination of vital capacity of the lungs in the case of patients with heart disease p Hunt, S.A., et al., ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, (12): p. e Kannel, W.B., et al., Vital capacity and congestive heart failure. The Framingham study. Circulation, (6): p Gottdiener, J.S., et al., Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol, (6): p Eriksson, H., et al., Risk factors for heart failure in the general population: the study of men born in Eur Heart J, (7): p Clennell, S., et al., Characterisation of smoking behaviour across the life course and its impact on decline in lung function and all-cause mortality: evidence from a British birth cohort. J Epidemiol Community Health, Yeh, H.C., et al., Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care, (4): p Fung, J.W., et al., Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest, (2): p Kraiczi, H., et al., Impairment of vascular endothelial function and left ventricular filling : association with the severity of apnea-induced hypoxemia during sleep. Chest, (4): p Marin, J.M., et al., Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet, (9464): p Kannel, W.B., H. Hubert, and E.A. Lew, Vital capacity as a predictor of cardiovascular disease: the Framingham study. Am Heart J, (2): p Gunnell, D., et al., Associations of height, leg length, and lung function with cardiovascular risk factors in the Midspan Family Study. J Epidemiol Community Health, (2): p Yeh, H.C., et al., Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care, (6): p Engstrom, G. and L. Janzon, Risk of developing diabetes is inversely related to lung function: a population-based cohort study. Diabet Med, (2): p
7 24. Enright, P.L., et al., Reduced vital capacity in elderly persons with hypertension, coronary heart disease, or left ventricular hypertrophy. The Cardiovascular Health Study. Chest, (1): p Schroeder, E.B., et al., Impaired lung function and subclinical atherosclerosis. The ARIC Study. Atherosclerosis, (2): p Marcus, E.B., et al., Pulmonary function as a predictor of coronary heart disease. Am J Epidemiol, (1): p Cook, D.G. and A.G. Shaper, Breathlessness, lung function and the risk of heart attack. Eur Heart J, (11): p Engstrom, G., et al., Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation, (20): p
ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized
More informationARIC Manuscript Proposal # PC Reviewed: 05/12/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 1508 PC Reviewed: 05/12/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hemostatic markers and risk of atrial fibrillation: the Atherosclerosis Risk
More informationARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority:
ARIC Manuscript Proposal #1233 PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: 1.a. Full Title: Subclinical atherosclerosis precedes type 2 diabetes in the ARIC study cohort
More informationARIC Manuscript Proposal # 1518
ARIC Manuscript Proposal # 1518 PC Reviewed: 5/12/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1. a. Full Title: Prevalence of kidney stones and incidence of kidney stone hospitalization in
More informationHeart Failure and COPD: Common Partners, Common Problems. Nat Hawkins Liverpool Heart and Chest Hospital
Heart Failure and COPD: Common Partners, Common Problems Nat Hawkins Liverpool Heart and Chest Hospital Disclosures: No conflicts of interest Common partners, common problems COPD in HF common partners
More informationARIC Manuscript Proposal #2099. PC Reviewed: 3/12/13 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal #2099 PC Reviewed: 3/12/13 Status: A Priority: 2 SC Reviewed: Status: Priority: 1. a. Full Title: Utility of biomarker panel, hstnt, NT-proBNP, and cystatin C to prediction of
More informationSupplementary Online Content
Supplementary Online Content Regan EA, Lynch DA, Curran-Everett D, et al; Genetic Epidemiology of COPD (COPDGene) Investigators. Clinical and radiologic disease in smokers with normal spirometry. Published
More informationARIC Manuscript Proposal #1491. PC Reviewed: 03/17/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal #1491 PC Reviewed: 03/17/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: The Association of Hemoglobin A1c with Depressive Symptoms in Persons with and
More information2/11/2017. Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox. Disclosures. Carl J. Lavie, MD, FACC, FACP, FCCP
Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox Carl J. Lavie, MD, FACC, FACP, FCCP Professor of Medicine Medical Director, Cardiac Rehabilitation and Preventive Cardiology
More informationOutline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?
Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Fernando Holguin MD MPH Director, Asthma Clinical & Research Program Center for lungs and Breathing University of Colorado
More informationTopic Page: congestive heart failure
Topic Page: congestive heart failure Definition: congestive heart f ailure from Merriam-Webster's Collegiate(R) Dictionary (1930) : heart failure in which the heart is unable to maintain an adequate circulation
More informationChoosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease. Greg Wellenius Joel Kaufman
Choosing Study Outcomes that Reflect Cardiovascular Disease: From Biomarkers to Burden of Disease Greg Wellenius Joel Kaufman Framework for Choosing Subclinical Outcomes To Study What clinical outcomes
More informationForced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality
Eur Respir J 2010; 36: 1002 1006 DOI: 10.1183/09031936.00042410 CopyrightßERS 2010 Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality H.M. Lee*,#, H. Le*, B.T.
More informationThe Impact of Smoking on Acute Ischemic Stroke
Smoking The Impact of Smoking on Acute Ischemic Stroke Wei-Chieh Weng, M.D. Department of Neurology, Chang-Gung Memorial Hospital, Kee-Lung, Taiwan Smoking related mortality Atherosclerotic vascular disease
More informationReduced lung function in midlife and cognitive impairment in the elderly
Page 1 of 5 Reduced lung function in midlife and cognitive impairment in the elderly Giuseppe Verlato, M.D. Ph.D Department of Diagnostics and Public Health University of Verona Verona, Italy Mario Olivieri,
More informationThis is a cross-sectional analysis of the National Health and Nutrition Examination
SUPPLEMENTAL METHODS Study Design and Setting This is a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) data 2007-2008, 2009-2010, and 2011-2012. The NHANES is
More informationImpaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events
Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts
More informationARIC Manuscript Proposal #2493. PC Reviewed: 2/10/15 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal #2493 PC Reviewed: 2/10/15 Status: A Priority: 2 SC Reviewed: Status: Priority: 1. a. Full Title: Potentially inappropriate medication use in older people: Prevalence and outcomes.
More informationARIC Manuscript Proposal #2426. PC Reviewed: 9/9/14 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal #2426 PC Reviewed: 9/9/14 Status: A Priority: 2 SC Reviewed: Status: Priority: 1a. Full Title: Statin drug-gene interactions and MI b. Abbreviated Title: CHARGE statin-gene GWAS
More informationOzone and Health: Clinical Studies. Mark W. Frampton MD University of Rochester Medical Center Rochester, NY
Ozone and Health: Clinical Studies Mark W. Frampton MD University of Rochester Medical Center Rochester, NY QUESTIONS What do we know about respiratory effects of ozone? Are there acute cardiovascular
More informationChapter 4: Cardiovascular Disease in Patients With CKD
Chapter 4: Cardiovascular Disease in Patients With CKD The prevalence of cardiovascular disease is 68.8% among patients aged 66 and older who have CKD, compared to 34.1% among those who do not have CKD
More informationProf. Samir Morcos Rafla Alexandria Univ. Cardiology Dept.
Obesity as a risk factor for Atrial Fibrillation Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept. CardioAlex 2010 smrafla@hotmail.com 1 Obesity has reached epidemic proportions in the United
More informationLecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors
Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life
More informationDoes quality of life predict morbidity or mortality in patients with atrial fibrillation (AF)?
Does quality of life predict morbidity or mortality in patients with atrial fibrillation (AF)? Erika Friedmann a, Eleanor Schron, b Sue A. Thomas a a University of Maryland School of Nursing; b NEI, National
More informationTable 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings
CMS-1345-P 174 Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings AIM: Better Care for Individuals 1. Patient/Care Giver Experience
More informationLnformation Coverage Guidance
Lnformation Coverage Guidance Coverage Indications, Limitations, and/or Medical Necessity Abstract: B-type natriuretic peptide (BNP) is a cardiac neurohormone produced mainly in the left ventricle. It
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationSupplementary Online Content. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and
1 Supplementary Online Content 2 3 4 5 6 Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and cardiometabolic risk factor management on sympton burden and severity in patients with atrial
More informationDiabetes and the Heart
Diabetes and the Heart Association of Specialty Professors April 4, 2013 Jorge Plutzky, MD Co-Director, Preventive Cardiology Director, The Lipid Clinic Cardiovascular Division Brigham and Women s Hospital
More informationPulmonary Function Abnormalities in Patients with Metabolic Syndrome
Proceeding S.Z.P.G.M.I. Vol: 27(2): pp. 69-73, 2013. Pulmonary Function Abnormalities in Patients with Metabolic Syndrome Talha Mahmud, 1 Muhammad Siddique 2 and Anjum Naveed 3 1 Department of Pulmonology,
More informationReview of guidelines for management of dyslipidemia in diabetic patients
2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University
More informationJUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012
SAMUEL TCHWENKO, MD, MPH Epidemiologist, Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section; Division of Public Health NC Department of Health & Human Services JUSTUS WARREN TASK
More informationHEART and LUNG. Heart failure and COPD Χ. ΑΔΑΜΟΠΟΥΛΟΣ ΓΝΘ «ΑΓΙΟΣ ΠΑΥΛΟΣ»
HEART and LUNG Heart failure and COPD Χ. ΑΔΑΜΟΠΟΥΛΟΣ ΓΝΘ «ΑΓΙΟΣ ΠΑΥΛΟΣ» Prevalence of concurrent HF and COPD 8 52 % of HF patients have concurrent COPD More common in male HF patients Prevalence increases
More informationCardiovascular Diseases in CKD
1 Cardiovascular Diseases in CKD Hung-Chun Chen, MD, PhD. Kaohsiung Medical University Taiwan Society of Nephrology 1 2 High Prevalence of CVD in CKD & ESRD Foley RN et al, AJKD 1998; 32(suppl 3):S112-9
More informationPulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?
Pulmonary Function Testing: Concepts and Clinical Applications David M Systrom, MD Potential Conflict Of Interest Nothing to disclose pertinent to this presentation BRIGHAM AND WOMEN S HOSPITAL Harvard
More informationCLINICAL PRACTICE GUIDELINE
CLINICAL PRACTICE GUIDELINE Procedure: Congestive Heart Failure Guideline Review Cycle: Biennial Reviewed By: Amish Purohit, MD, MHA, CPE, FACHE Review Date: November 2014 Committee Approval Date: 11/12/2014
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationCorrelation of novel cardiac marker
Correlation of novel cardiac marker and mortality in EGAT population. Soluble ST2 hscrp Poh Chanyavanich, MD SukitYamwong, MD Piyamitr Sritara, MD Ramathibodi hospital Background hscrp - the most widely
More informationHigh Risk OSA n = 5,359
Table S1 Prevalence of atrial fibrillation (AF) identified using different methods in participants with high and low risk obstructive sleep apnea (). High Risk n = 5,359 Low Risk n = 14,992 SR-AF (%) 467
More informationSleep Apnea: Vascular and Metabolic Complications
Sleep Apnea: Vascular and Metabolic Complications Vahid Mohsenin, M.D. Professor of Medicine Yale University School of Medicine Director, Yale Center for Sleep Medicine Definitions Apnea: Cessation of
More informationFEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,
More informationDiabetes and the Heart
Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 9: Cardiovascular Disease in Patients With ESRD Cardiovascular disease is common in ESRD patients, with atherosclerotic heart disease and congestive heart
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationSupplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
More information4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?
HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL
More informationPrevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient
Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient The Issue of Primary Prevention of A.Fib. (and Heart Failure) and not the Prevention of Recurrent A.Fib. after Electroconversion
More informationComorbidities in HF COPD Chronic Obstructive Pulmonary Disease Gerasimos Filippatos Athens, Greece
Comorbidities in HF COPD Chronic Obstructive Pulmonary Disease Gerasimos Filippatos Athens, Greece Epidemiology of heart failure in chronic obstructive pulmonary disease (COPD) patients and vice versa.
More informationHEART FAILURE IN WOMEN. Marian Limacher, MD Division of Cardiovascular Medicine University of Florida
HEART FAILURE IN WOMEN Marian Limacher, MD Division of Cardiovascular Medicine University of Florida Outline Epidemiology Clinical Overview Why HF is such a challenge State of the Field Heart Failure Adjudication
More informationBiases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University
Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of
More informationChapter 4: Cardiovascular Disease in Patients With CKD
Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for
More informationAHA Sleep Apnea and Cardiovascular Disease. Slide Set
AHA 2008 Sleep Apnea and Cardiovascular Disease Slide Set Based on the AHA 2008 Scientific Statement Sleep Apnea and Cardiovascular Disease Virend K. Somers, MD, DPhil, FAHA, FACC Mayo Clinic and Mayo
More informationHeart Failure and Sleep Disordered Breathing (SDB) Unhappy Bedfellows
Question Heart Failure and Sleep Disordered Breathing (SDB) Unhappy Bedfellows 1 ResMed 2012 07 2 ResMed 2012 07 Open Airway 3 ResMed 2012 07 Flow Limitation Snore 4 ResMed 2012 07 Apnoea 5 ResMed 2012
More informationChapter 4: Cardiovascular Disease in Patients with CKD
Chapter 4: Cardiovascular Disease in Patients with CKD The prevalence of cardiovascular disease (CVD) was 65.8% among patients aged 66 and older who had chronic kidney disease (CKD), compared to 31.9%
More informationThe Diabetes Link to Heart Disease
The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM
More informationCVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic
CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This
More informationDirect and indirect CV effects of current drugs and those in development
Direct and indirect CV effects of current drugs and those in development Heribert Staudinger CSRC MARCH 201 Cardiac Manifestations of COPD Cardiovascular Disease is probably the most frequent and most
More informationPopulation-based study of lung function and incidence of heart failure hospitalisations
Department of Clinical Sciences, Lund University, Malmö University Hospital, Sweden Correspondence to Professor Gunnar Engström, Cardiovascular Epidemiology Research Group, UMAS, CRC, 20502 Malmö, Sweden;
More information2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary
2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease Becky McKibben, MPH; Seth
More informationCOPD as a comorbidity of heart failure in elderly patients
COPD as a comorbidity of heart failure in elderly patients Professor Mitja Lainscak, MD, PhD, FESC, FHFA Departments of Cardiology and Research&Education, General Hospital Celje Faculty of Medicine, University
More information10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor
Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure
More informationTrial to Reduce. Aranesp* Therapy. Cardiovascular Events with
Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationAssessment of Pulmonary Artery Pressure in Chronic Obstructive Pulmonary Disease Patients without Resting Hypoxemia
The Egyptian Journal of Hospital Medicine (July 2018) Vol. 73 (2), Page 6021-6027 Assessment of Pulmonary Artery Pressure in Chronic Obstructive Pulmonary Disease Patients without Resting Hypoxemia Muhammed
More informationNew indicators to be added to the NICE menu for the QOF and amendments to existing indicators
New indicators to be added to the for the QOF and amendments to existing indicators 1 st September 2015 Version 1.1 This document was originally published on 3 rd August 2015, it has since been updated.
More informationEugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG
Diabetes Mellitus: Update 7 What is the unifying basis of this vascular disease? Eugene J. Barrett, MD, PhD Professor of Internal Medicine and Pediatrics Director, Diabetes Center and GCRC Health System
More informationTerm-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY
MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple
More informationDiagnosis is it really Heart Failure?
ESC Congress Munich - 25-29 August 2012 Heart Failure with Preserved Ejection Fraction From Bench to Bedside Diagnosis is it really Heart Failure? Prof. Burkert Pieske Department of Cardiology Med.University
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Peripheral arterial disease Potential output:
More informationSUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.
Supplementary Figure S1. Cohort definition flow chart. Supplementary Table S1. Baseline characteristics of study population grouped according to having developed incident CKD during the follow-up or not
More informationEgyptian Hypertension Guidelines
Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich
More information8/10/2012. Education level and diabetes risk: The EPIC-InterAct study AIM. Background. Case-cohort design. Int J Epidemiol 2012 (in press)
Education level and diabetes risk: The EPIC-InterAct study 50 authors from European countries Int J Epidemiol 2012 (in press) Background Type 2 diabetes mellitus (T2DM) is one of the most common chronic
More informationWellness: Concepts and Applications 8 th Edition Anspaugh, Hamrick, Rosato
Wellness: Concepts and Applications 8 th Edition Anspaugh, Hamrick, Rosato Preventing Cardiovascular Disease Chapter 2 Cardiovascular Disease the leading cause of death in the U.S. 35.3% of all deaths
More informationStatins in lung disease
Statins in lung disease Associate Professor Robert Young BMedSc, MBChB, DPhil (Oxon), FRACP, FRCP University of Auckland, New Zealand Smoking and its complications Respiratory COPD Cardiovascular CAD Smoking
More informationORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults
ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationEpidemiologic Methods in the Study of Sudden Cardiac Death
Epidemiologic Methods in the Study of Sudden Cardiac Death Clinical Epidemiology and Biostatistics Mahidol University Bangkok Ross J. Simpson Jr, MD, PhD Division of Cardiology University of North Carolina
More information2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters
GOLD Objectives To provide a non biased review of the current evidence for the assessment, diagnosis and treatment of patients with COPD. To highlight short term and long term treatment objectives organized
More informationAdult Pre Participation Screening and Exercise Prescription Practicum
Adult Pre Participation Screening and Exercise Prescription Practicum Objectives of this exercise: To administer pre participation screening and risk stratification for clients To write an appropriate
More informationConsensus document: Screening and Prevention of Atrial Fibrillation
Consensus document: Screening and Prevention of Atrial Fibrillation Yong-Seog Oh, M.D.,Ph.D. Division of Cardiology, Department of Internal Medicine, Seoul St. Mary s Hospital, College of Medicine, The
More informationHypertension Management Controversies in the Elderly Patient
Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No
More informationAutonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors
Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti
More informationChronic Obstructive Pulmonary Disease Guidelines and updates
Chronic Obstructive Pulmonary Disease Guidelines and updates October 20, 2018 Saratoga Springs, NY COPD (Chronic obstructive pulmonary disease) is a major cause of mortality and morbidity in the United
More informationSGRQ Questionnaire assessing respiratory disease-specific quality of life. Questionnaire assessing general quality of life
SUPPLEMENTARY MATERIAL e-table 1: Outcomes studied in present analysis. Outcome Abbreviation Definition Nature of data, direction indicating adverse effect (continuous only) Clinical outcomes- subjective
More informationStudy of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri
Original Research Article Study of rhythm disturbances in acute myocardial infarction in Government Dharmapuri Medical College Hospital, Dharmapuri P. Sasikumar * Department of General Medicine, Govt.
More informationCOPD and environmental risk factors other than smoking. 14. Summary
COPD and environmental risk factors other than smoking 14. Summary Author : P N Lee Date : 7 th March 2008 1. Objectives and general approach The objective was to obtain a good insight from the available
More informationThe Aging Lung. Sidney S. Braman MD FACP FCCP Professor of Medicine Brown University Providence RI
The Aging Lung Sidney S. Braman MD FACP FCCP Professor of Medicine Brown University Providence RI Is the respiratory system of the elderly different when compared to younger age groups? Respiratory Changes
More informationThe contractor establishes and maintains a register of patients with AF
Atrial Fibrillation The contractor establishes and maintains a register of patients with AF G5731 Those patients with AF in whom there is a record of CHADS2 score of 1, the % of patients who are currently
More informationCOPD: early detection, screening and case-finding: what is the evidence? Prof. Jan-Willem Lammers, Md PhD Department of Respiratory Diseases
COPD: early detection, screening and case-finding: what is the evidence? Prof. Jan-Willem Lammers, Md PhD Department of Respiratory Diseases «If you test one smoker with cough every day You will diagnose
More informationSleep Apnea and Heart Failure
Sleep Apnea and Heart Failure Micha T. Maeder, MD Cardiology Division Kantonsspital St. Gallen Switzerland micha.maeder@kssg.ch Sleep Disordered Breathing (SDB) in HFrEF 700 HFrEF patients (LVEF
More informationYuriy Feschenko, Liudmyla Iashyna, Ksenia Nazarenko and Svitlana Opimakh
2018; 7(1): 74-78 ISSN (E): 2277-7695 ISSN (P): 2349-8242 NAAS Rating: 5.03 TPI 2018; 7(1): 74-78 2018 TPI www.thepharmajournal.com Received: 11-11-2017 Accepted: 12-12-2017 Yuriy Feschenko Liudmyla Iashyna
More informationCardiovascular Diseases and Diabetes
Cardiovascular Diseases and Diabetes LEARNING OBJECTIVES Ø Identify the components of the cardiovascular system and the various types of cardiovascular disease Ø Discuss ways of promoting cardiovascular
More informationVitamin D & Cardiovascular Disease
Vitamin D & Cardiovascular Disease Disclosures None Vitamin D Objectives: Discuss the basics of vitamin D metabolism Discuss the role of vitamin D deficiency in the development of coronary disease Review
More informationDisclosures. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease May 14, 2016 Orlando, FL COPD (Chronic obstructive pulmonary disease) is a major cause of mortality and morbidity in the United States. Alarmingly, COPD recently became
More informationEpidemiologic Measure of Association
Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2
More informationMeasure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner
2011 EHR Measure Specifications The specifications listed in this document have been updated to reflect clinical practice guidelines and applicable health informatics standards that are the most current
More informationSurvival Associated with Two Sets of Diagnostic Criteria for Congestive Heart Failure
American Journal of Epidemiology Copyright 2004 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 160, No. 7 Printed in U.S.A. DOI: 10.1093/aje/kwh268 Survival Associated
More informationESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study
ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study Statistical modelling details We used Cox proportional-hazards
More informationOver the last several years various national and
Recommendations for the Management of COPD* Gary T. Ferguson, MD, FCCP Three sets of guidelines for the management of COPD that are widely recognized (from the European Respiratory Society [ERS], American
More informationInvestigating the Frequency of Atherosclerosis Risk Factors in Patients Suffering from X Syndrome
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2016, 5, 10:84-90 Investigating the Frequency of Atherosclerosis Risk Factors in Patients
More information